Home > News > Foreword – European Journal of Arrhythmia & Electrophysiology. 2018;4(2):41
Arrhythmia
Read Time: 2 mins

Foreword – European Journal of Arrhythmia & Electrophysiology. 2018;4(2):41

Published Online: December 3rd 2018 European Journal of Arrhythmia & Electrophysiology. 2018;4(2):41
Authors: Tom De Potter
Quick Links:
Article
Article Information
Article:

 

This edition of European Journal of Arrhythmia & Electrophysiology features a selection of reviews in atrial fibrillation that examine and expand the knowledge base on the mechanisms of disease and its effective management. In addition, there is a timely practical guide suited to reinforcing the core skills for implanting electronic devices. Martin Borggrefe sheds light on sudden cardiac death – it is clear that risk stratification remains a major unresolved challenge and that prevention with a multi-disciplinary approach, for a phenomenon affecting millions every year, may offer great benefits to individuals and to society alike.

With the release of the ‘European Heart Rhythm Association (EHRA) practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation’, Hein Heidbuchel presents the rationale and history of the developments and, most importantly, an overview of the new guidance for a condition with equally devastating consequences and equally large potential for preventive therapy. While there is increasing evidence for the initiation of non-vitamin K antagonist oral anticoagulants, there is a background of prescribing uncertainty, especially in the context of polypharmacy, and a lack of head-to-head data supporting the selection of specific agents – this new guide is particularly welcome in assisting physicians in decision-making for daily questions.

As physicians and their healthcare systems seek to optimise resource usage, there is discussion on the use of electronic and mobile health technologies, their benefits, integration into existing systems and the regulatory considerations in their application. With increasing technological possibilities, and their associated expenses, optimised resource allocation is set to be one of the most rewarding fields of research for the next decade. In an expert interview, Martin Cowie discusses the use of electronic and mobile health in chronic heart failure.

Looking at emerging technology that seeks to move from academic interest to clinical practice, Michael Derndorfer and Helmut Pürerfellner examine the evidence and remaining questions for high-density mapping catheters, examining their role in daily clinical interventions as well as in advancing basic insights in arrhythmia mechanisms.

Particular thanks to the authors who have contributed to this edition and produced insightful, thought-provoking and clinically relevant contributions to help improve cardiac disease outcomes. I hope you find its content both intellectually stimulating and useful for your practice.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72